French pharma major Sanofi has opened negotiations to sell a 50% controlling stake in its consumer health business Opella to ...

High-yield savings accounts are another possible option for funds from a maturing CD — and a better choice than long-term CDs ...

France will take a stake in Sanofi's Opella through the Public Investment Bank (BPI), finance minister Antoine Armand said on ...

Though Citibank offers customers a range of CD terms and rates, most are uncompetitive. For a large bank, however, Citi has some inviting options. With just a $500 minimum deposit for all CDs ...

Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell a controlling stake in its consumer healthcare unit, Opella, the company ...

Sanofi and private equity firm CD&R are in negotiations to sell a 50% stake in Opella, Sanofi's consumer healthcare division. With a €16B valuation, Opella is the third-largest player in the global ...

you'll sell your CD on the secondary market. Brokered CDs typically offer flexible terms and higher interest rates than traditional CDs, but they do not compound interest. With Schwab CDs ...

Instead, you would sell your CD on the secondary market if you needed the money before your term ends. If you're looking to use CDs as part of your savings strategy, Edward Jones' brokered CDs may ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its ...

Sanofis Exclusive Negotiations with Clayton Dubilier Rice Sanofi (NASDAQ: SNY) announced on Monday that it has entered ...

Our picks for the best CD rates are offered by Quontic Bank (4.95%), Barclays (4.65%) and Ally Bank (4.40%). We’ve put together a list of the best CD rates from our top-rated banks, credit ...

Under the proposed deal, the PE firm would take a controlling 50% stake in Sanofi’s Opella unit, with state-owned Bpifrance ...